The association between LRRC56 (Leucine Rich Repeat Containing 56) and Schimmelpenning-Feuerstein-Mims Syndrome is well established and manually curated, drawing on a single expert-curated source, which records pathogenic and likely-pathogenic variants.
Sources1
Clinical variants26
Symptoms85
Compounds0
Trials0
Publications7
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.